🟢 BioLineRx is trading 9.6% up in pre-market ahead of Q2 results

BioLineRx is trading 9.6% up at $2.85 after closing at $2.60 on August 28, 2026, ahead of scheduled second-quarter results.

• Results are due before the August 31 market open, followed by an 8:30 a.m. EDT conference call.
• BioLineRx announced a $3.75 million registered direct offering and concurrent private placement, priced at $2.78 per ADS and expected to close August 31.